Pneumonia bacterial
RecruitingA study to evaluate the safety of OMN6 in patients with pneumonia caused by Acinetobacter baumannii bacteria.
- Disease:Pneumonia bacterial
- Substances:Saline
Italy- Participants:18–64 years · 65+ years
- Substances:Saline
Rare diseases
Investigational molecules
Locations
Via Festa Del Perdono 7, 20122 Milan, Italy
University Of Milan in Milan, Italy specialises in clinical trials of conditions such as Pneumonia bacterial, Lung disorder, and other specialisations. This site conducts important research.
The University of Milan’s Department of Infectious Diseases is conducting studies focused on hospital‑acquired bacterial pneumonia caused by Acinetobacter baumannii complex. These trials aim to assess safety and effectiveness of new antimicrobial agents, improving treatment options for patients on ventilators.
The site combines academic expertise with commercial collaboration, leveraging its Milan location to advance respiratory infection therapies.
Research at the University of Milan also targets COVID‑19 caused by SARS‑CoV‑2, evaluating therapeutic interventions to reduce disease progression and mortality in hospitalized patients.
These investigations are part of a European adaptive pandemic platform, reflecting the institution’s commitment to rapid, evidence‑based solutions for viral infections.
Clinical trials currently enrolling participants at this site.
Italy
ItalyMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.